Global Multiparameter Patient Monitoring Devices Market to Reach USD 6 Billion by 2025
|
By HospiMedica International staff writers Posted on 18 Mar 2020 |

Illustration
The global multiparameter patient monitoring devices market is expected to grow at a CAGR of over 4%, or record an incremental growth of around USD 1.32 billion, during the forecast period 2019−2025 to reach USD 6 billion in 2025. These are the latest findings of Arizton (Chicago, IL, USA), a provider of market research solutions.
Technological advancements in medical devices, medicine, and public health, coupled with increasing awareness among consumers about personal hygiene, and nutrition, has increased life expectancy in the past few years across the globe. However, increased life expectancy, coupled with falling birthrates, has given rise to an increasingly aging population and the need for advanced medical technology, such as multi-parameter patient monitors.
Based on devices, the portable monitoring devices segment is likely to grow at the fastest CAGR during the forecast period, driven by the ease of remotely monitoring and availability of portable features which are expected to increase their application in-home care settings and enable real-time vital signs monitoring. On the basis of acuity level, the low-acuity level segment is expected to grow at the fastest rate during the forecast period, driven mainly by the low cost of low-acuity monitors, which is expected to boost the demand for these devices in the developed and developing regions.
Based on patient group, the geriatric group segment dominates the multiparameter patient monitoring devices market and is expected to grow at the fastest rate due to the increasing elderly population that is vulnerable to chronic diseases and often requires immediate medical interventions. On the basis of end-user, the ambulatory surgery centers (ASCs) segment is likely to grow at the fastest rate as these centers are cost-effective and offer high-quality care with a minimal indirect treatment cost.
Geographically, North America dominated the global multiparameter patient monitoring devices market in 2019 and is expected to grow at a steady pace due to the increasing old age population, moderate increase in ICU admission, and availability of advanced technology for RPM in the region. The presence of a large pool of population with several chronic diseases, coupled with high acceptance of advanced and innovative multiparameter patient monitoring devices, is likely to support the region's dominance of the global multiparameter patient monitoring devices market.
Related Links:
Arizton
Technological advancements in medical devices, medicine, and public health, coupled with increasing awareness among consumers about personal hygiene, and nutrition, has increased life expectancy in the past few years across the globe. However, increased life expectancy, coupled with falling birthrates, has given rise to an increasingly aging population and the need for advanced medical technology, such as multi-parameter patient monitors.
Based on devices, the portable monitoring devices segment is likely to grow at the fastest CAGR during the forecast period, driven by the ease of remotely monitoring and availability of portable features which are expected to increase their application in-home care settings and enable real-time vital signs monitoring. On the basis of acuity level, the low-acuity level segment is expected to grow at the fastest rate during the forecast period, driven mainly by the low cost of low-acuity monitors, which is expected to boost the demand for these devices in the developed and developing regions.
Based on patient group, the geriatric group segment dominates the multiparameter patient monitoring devices market and is expected to grow at the fastest rate due to the increasing elderly population that is vulnerable to chronic diseases and often requires immediate medical interventions. On the basis of end-user, the ambulatory surgery centers (ASCs) segment is likely to grow at the fastest rate as these centers are cost-effective and offer high-quality care with a minimal indirect treatment cost.
Geographically, North America dominated the global multiparameter patient monitoring devices market in 2019 and is expected to grow at a steady pace due to the increasing old age population, moderate increase in ICU admission, and availability of advanced technology for RPM in the region. The presence of a large pool of population with several chronic diseases, coupled with high acceptance of advanced and innovative multiparameter patient monitoring devices, is likely to support the region's dominance of the global multiparameter patient monitoring devices market.
Related Links:
Arizton
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







